CN103041336B - Traditional Chinese medicine composition for treating coronary heart disease - Google Patents
Traditional Chinese medicine composition for treating coronary heart disease Download PDFInfo
- Publication number
- CN103041336B CN103041336B CN201210561123.3A CN201210561123A CN103041336B CN 103041336 B CN103041336 B CN 103041336B CN 201210561123 A CN201210561123 A CN 201210561123A CN 103041336 B CN103041336 B CN 103041336B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a traditional Chinese medicine composition for treating the coronary heart disease.The traditional Chinese medicine composition is composed of raw traditional Chinese medicine materials in parts by weight as follows: 20-45 parts of astragalus, 15-25 parts of cassia twigs, 5-15 parts of peach seeds, 5-15 parts of safflowers, 10-30 parts of salvia miltiorrhiza, 5-15 parts of Sichuan lovage rhizomes, 10-20 parts of angelica, 20-40 parts of unprocessed rehmannia roots, 5-15 parts of prepared common monkshood branched roots, 5-15 parts of dried ginger, 5-15 parts of platycodon grandiflorum, 15-45 parts of white paeony roots, 15-25 parts of codonopsis pilosula, 5-15 parts of leeches, 20-40 parts of allium macrostemon, 2-10 parts of ephedra herbs and 5-15 parts of radix glycyrrhizae preparata. The traditional Chinese medicine composition has the functions of strengthening the spleen and tonifying the lung, reinforcing the kidney to strengthening yang, nourishing the blood and the liver, nourishing yin and generating body fluid, nourishing spirit and replenishing the blood, activating the blood and removing the blood stasis; has a remarkable effect in treating the coronary heart disease, and is reliable in functions; and is wide in component sources, easy to prepare, mild in medicine property, and free of toxic and side effects.
Description
Technical field
The present invention relates to a kind of pharmaceutical product of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of coronary heart disease.
Background technology
Coronary heart disease, is the abbreviation of coronary heart disease, is common clinically frequently-occurring disease, commonly encountered diseases.Modern medicine is thought, coronary heart disease is due to coronary atherosclerosis, or thrombosis is attached on coronary blood tube wall and causes coronary stricture, reduce by coronary artery blood flow, when cardiac load increases suddenly, need blood volume to increase, exceed the compensatory capacity of coronary artery blood supply, or need blood volume not increase, but coronary spasm, reduced blood flow or above-mentioned factor exists simultaneously, all can cause heart sharply, temporary transient ischemia, anoxia and angina pectoris occurs.At present, the method for the treatment of coronary heart disease is varied, and treatment means one as main in doctor trained in Western medicine is coronary artery dilator, the 2nd, the formation of anti-tampon and the gathering of thrombosis, cause the narrow of tube chamber, the minimizing of blood flow, but most of curative effects are unstable, and the course of disease is long, outbreak repeatedly, effect is undesirable, although many hospitals can carry out coronary artery expansion art in recent years, price is more expensive, and there is certain risk, most of patients can not be accepted, and be subject to again the restriction of age and armarium, can not extensively popularize.
The traditional Chinese medical science thinks, coronary heart disease main manifestations is deficiency in origin and excess in superficiality, simulataneous insufficiency and excessive, and its deficiency in origin can have yang blood and qi virtual loss, real is that the stagnation of QI, cold coagulation, expectorant are turbid, blood stasis, and again can be mutually sick each other, its pathogenesis is blockage of the cardiac vessels, its sick position taking the heart as and relevant with the dirty functional disorder of liver,spleen,kidney three.
According to theory of Chinese medical science, for the pathogeny of coronary heart disease, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome the deficiencies in the prior art, the invention provides a kind of prepare easy, cost is low, the Chinese medicine composition of evident in efficacy, the treatment coronary heart disease that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of coronary heart disease, is characterized in that: its raw material of Chinese medicine by following weight portion forms: Radix Astragali 20-45 part, Ramulus Cinnamomi 15-25 part, Semen Persicae 5-15 part, Flos Carthami 5-15 part, Radix Salviae Miltiorrhizae 10-30 part, Rhizoma Chuanxiong 5-15 part, Radix Angelicae Sinensis 10-20 part, Radix Rehmanniae 20-40 part, Radix Aconiti Lateralis Preparata 5-15 part, Rhizoma Zingiberis 5-15 part, Radix Platycodonis 5-15 part, Radix Paeoniae Alba 15-45 part, Radix Codonopsis 15-25 part, Hirudo 5-15 part, Bulbus Allii Macrostemonis 20-40 part, Herba Ephedrae 2-10 part, Radix Glycyrrhizae Preparata 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of coronary heart disease, is characterized in that: its raw material of Chinese medicine by following weight portion forms: 30 parts of the Radixs Astragali, 20 parts of Ramulus Cinnamomi, 10 parts, Semen Persicae, 10 parts, Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Rhizoma Chuanxiongs, 15 parts of Radix Angelicae Sinensis, 30 parts of Radix Rehmanniae, 10 parts of Radix Aconiti Lateralis Preparatas, 10 parts of Rhizoma Zingiberiss, 10 parts of Radix Platycodoniss, 30 parts of the Radix Paeoniae Albas, 20 parts of Radix Codonopsis, 10 parts of Hirudos, 30 parts of Bulbus Allii Macrostemonis, 6 parts, Herba Ephedrae, 10 parts of Radix Glycyrrhizae Preparatas.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: the Radix Astragali has that benefiting QI for strengthening the superficies, tonifying the lung spleen invigorating, arresting sweating are admittedly de-, wind dispelling is transported malicious effect; Ramulus Cinnamomi has effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Semen Persicae has effect of blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Flos Carthami has effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain; Radix Salviae Miltiorrhizae has effect of promoting blood flow to regulate menstruation, blood stasis dispelling eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Rhizoma Chuanxiong has effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation; Radix Rehmanniae has effect of clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting, pain relieving regulating menstruation; Radix Aconiti Lateralis Preparata has recuperating depleted YANG and rescuing the patient from collapse, mends effect fiery supporing yang, dispersing cold for relieving pain; Rhizoma Zingiberis has that warming spleen and stomach for dispelling cold, recuperating depleted YANG are promoted blood circulation, effect of warming the lung to resolve fluid-retention; Radix Platycodonis has lung qi dispersing and eliminates the phlegm, fosters the spirit of nobility and enrich blood, sharp the five internal organs, mend effect of five kinds of over strain; The Radix Paeoniae Alba has effect of nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing receipts antiperspirant; Radix Codonopsis has effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; Hirudo has promoting blood circulation and breaking stagnation, effect of the removing food stagnancy that stimulates the menstrual flow; Bulbus Allii Macrostemonis has that warming middle-JIAO activates yang, effect of therapeutic method to keep the adverse QI flowing downwards eliminating stagnation; Herba Ephedrae has effect of relieving the exterior syndrome by diaphoresis, depressed lung-energy dispersing, inducing diuresis to remove edema; Radix Glycyrrhizae Preparata has effect of spleen reinforcing stomach function regulating, Yiqi and vein recovery.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, complements each other using, and has synergism, play altogether spleen invigorating lung benefiting, reinforcing the kidney and supporting YANG, nourishing blood to suppress the hyperactive liver, YIN nourishing and the production of body fluid promoting, foster the spirit of nobility enrich blood, effect of blood circulation promoting and blood stasis dispelling, the treatment of coronary heart disease is reached to treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, does not occur toxic and side effects, and effective percentage reaches 90%, cure rate 65%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 30g, Ramulus Cinnamomi 20g, Semen Persicae 10g, Flos Carthami 10g, Radix Salviae Miltiorrhizae 20g, Rhizoma Chuanxiong 10g, Radix Angelicae Sinensis 15g, Radix Rehmanniae 30g, Radix Aconiti Lateralis Preparata 10g, Rhizoma Zingiberis 10g, Radix Platycodonis 10g, Radix Paeoniae Alba 30g, Radix Codonopsis 20g, Hirudo 10g, Bulbus Allii Macrostemonis 30g, Herba Ephedrae 6g, Radix Glycyrrhizae Preparata 10 g.
Embodiment 2
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 35g, Ramulus Cinnamomi 25g, Semen Persicae 5g, Flos Carthami 15g, Radix Salviae Miltiorrhizae 10g, Rhizoma Chuanxiong 15g, Radix Angelicae Sinensis 10g, Radix Rehmanniae 40g, Radix Aconiti Lateralis Preparata 5g, Rhizoma Zingiberis 15g, Radix Platycodonis 5g, Radix Paeoniae Alba 35g, Radix Codonopsis 15g, Hirudo 15g, Bulbus Allii Macrostemonis 20g, Herba Ephedrae 10g, Radix Glycyrrhizae Preparata 5g.
Embodiment 3
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 25g, Ramulus Cinnamomi 15g, Semen Persicae 15g, Flos Carthami 5g, Radix Salviae Miltiorrhizae 30g, Rhizoma Chuanxiong 5g, Radix Angelicae Sinensis 20g, Radix Rehmanniae 25g, Radix Aconiti Lateralis Preparata 15g, Rhizoma Zingiberis 8g, Radix Platycodonis 12g, Radix Paeoniae Alba 20g, Radix Codonopsis 25g, Hirudo 12g, Bulbus Allii Macrostemonis 40g, Herba Ephedrae 5g, Radix Glycyrrhizae Preparata 15g.
Embodiment 4
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 20g, Ramulus Cinnamomi 20g, Semen Persicae 12g, Flos Carthami 12g, Radix Salviae Miltiorrhizae 15g, Rhizoma Chuanxiong 8g, Radix Angelicae Sinensis 12g, Radix Rehmanniae 35g, Radix Aconiti Lateralis Preparata 8g, Rhizoma Zingiberis 5g, Radix Platycodonis 15g, Radix Paeoniae Alba 45g, Radix Codonopsis 20g, Hirudo 5g, Bulbus Allii Macrostemonis 25g, Herba Ephedrae 2g, Radix Glycyrrhizae Preparata 8g.
Embodiment 5
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine by following weight proportion forms: Radix Astragali 45g, Ramulus Cinnamomi 25g, Semen Persicae 8g, Flos Carthami 8g, Radix Salviae Miltiorrhizae 25g, Rhizoma Chuanxiong 12g, Radix Angelicae Sinensis 15g, Radix Rehmanniae 20g, Radix Aconiti Lateralis Preparata 12g, Rhizoma Zingiberis 12g, Radix Platycodonis 10g, Radix Paeoniae Alba 15g, Radix Codonopsis 15g, Hirudo 8g, Bulbus Allii Macrostemonis 35g, Herba Ephedrae 4g, Radix Glycyrrhizae Preparata 12g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soak 15～20 minutes, then add water and do not have approximately 6 centimetres of powder, decoct.At a simmer, adopt intense fire to decoct, after boiling, use slow fire boiling 20～30 minutes; Second decocts, and adds water and does not have approximately 4 centimetres of powder, after water boils, decocts 15～20 minutes.Decoct extracting juice twice, merge.
Treat a Chinese medicine composition for coronary heart disease, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 100 examples, 30～65 years old age.
Two, usage and dosage: when clinical practice, the amounts of components in compositions is taken the circumstances into consideration increase and decrease according to patient's body weight and age.One day potion, the about 300ml of twice extracting juice of decocting, point morning, evening take for twice.It within seven days, is a course for the treatment of.
Three, criterion of therapeutical effect:
(1) recovery from illness: sings and symptoms disappears or substantially disappears;
(2) effective: sings and symptoms is most of to take a turn for the better;
(3) effective: a sings and symptoms part takes a turn for the better;
(4) invalid; Sings and symptoms is all not improved, and symptom is as front.
Four, therapeutic effect: in this clinical observation case, take medicine 2-5 the course for the treatment of, recovery from illness 65 examples, follow up a case by regular visits to and have no recurrence; Effective 20 examples, effective 5 examples, invalid 10 examples.During treatment, there is not toxic and side effects.
Five, model case:
Case 1:
Cai, man, 47 years old.Main suit and medical history: dizzy more than 3 years uncomfortable in chest, increase the weight of 2 weeks.Examine as coronary heart disease.The traditional Chinese medical science is examined and is seen: cardiopalmus, and uncomfortable in chest, dizzy, weak, aversion to cold and cold limbs, loose stool, edema of lower limbs, lustreless complexion, words are purple dark, thin white fur of tongue, deep-slow pulse and thin.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, symptom greatly takes a turn for the better; Continue to take 1 course for the treatment of, symptom disappears substantially.
Case 2:
Late certain, man, 49 years old.Because of pareordia discomfort, uncomfortable in chest nervous before 2 years, examine as coronary heart disease at examination in hospital.First quarter moon cause is busy with one's work, and operating pressure is large, and burst precordialgia fixing does not move that companion is uncomfortable in chest, cardiopalmus, malaise, electrocardio diagram: 1. sinus tachycardia; 2. I, V5, V6T ripple are inverted, patient's obesity, and happiness food rich and fatty diet, lacks motion, abundant expectoration at ordinary times at ordinary times.Inspection is shown in that the thin white matter of tongue is fat, and the end is reflected livid purple, a little less than heavy cun of thready pulse, and GUAN-pulse band string.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, state of an illness basic controlling; Continue to take 2 courses for the treatment of, symptom disappears completely.After one month, do not follow up a case by regular visits to and do not recur again.
Case 3:
Wang, female, 65 years old.On August 25th, 2011 is medical.Readme: front pain uncomfortable in chest is shown effect more than 2 years repeatedly, takes western medicines in treatment, time while sending out only, have no improvement.1 month unexpected left front breast severe pain of cause, with losing heart, time cough and spit white thick expectorant, companion is dizzy sleepy, cardiopalmus.Inspection is shown in: light red tongue and dark, and sublingual vein stasis of blood purple, tongue is greasy in vain, deep and tense pulse.Be diagnosed as coronary heart disease.Take 3 courses for the treatment of of pharmaceutical treatment prepared by Chinese medicine composition of the present invention, symptom disappears completely.
Claims (2)
1. a Chinese medicine composition for the treatment of coronary heart disease, is characterized in that: its raw material of Chinese medicine by following weight portion forms: Radix Astragali 20-45 part, Ramulus Cinnamomi 15-25 part, Semen Persicae 5-15 part, Flos Carthami 5-15 part, Radix Salviae Miltiorrhizae 10-30 part, Rhizoma Chuanxiong 5-15 part, Radix Angelicae Sinensis 10-20 part, Radix Rehmanniae 20-40 part, Radix Aconiti Lateralis Preparata 5-15 part, Rhizoma Zingiberis 5-15 part, Radix Platycodonis 5-15 part, Radix Paeoniae Alba 15-45 part, Radix Codonopsis 15-25 part, Hirudo 5-15 part, Bulbus Allii Macrostemonis 20-40 part, Herba Ephedrae 2-10 part, Radix Glycyrrhizae Preparata 5-15 part.
2. a kind of Chinese medicine composition for the treatment of coronary heart disease according to claim 1, is characterized in that: its raw material of Chinese medicine by following weight portion forms: 30 parts of the Radixs Astragali, 20 parts of Ramulus Cinnamomi, 10 parts, Semen Persicae, 10 parts, Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Rhizoma Chuanxiongs, 15 parts of Radix Angelicae Sinensis, 30 parts of Radix Rehmanniae, 10 parts of Radix Aconiti Lateralis Preparatas, 10 parts of Rhizoma Zingiberiss, 10 parts of Radix Platycodoniss, 30 parts of the Radix Paeoniae Albas, 20 parts of Radix Codonopsis, 10 parts of Hirudos, 30 parts of Bulbus Allii Macrostemonis, 6 parts, Herba Ephedrae, 10 parts of Radix Glycyrrhizae Preparatas.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210561123.3A CN103041336B (en) | 2012-12-21 | 2012-12-21 | Traditional Chinese medicine composition for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210561123.3A CN103041336B (en) | 2012-12-21 | 2012-12-21 | Traditional Chinese medicine composition for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103041336A CN103041336A (en) | 2013-04-17 |
| CN103041336B true CN103041336B (en) | 2014-06-25 |
Family
ID=48054347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210561123.3A Expired - Fee Related CN103041336B (en) | 2012-12-21 | 2012-12-21 | Traditional Chinese medicine composition for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041336B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103566345B (en) * | 2013-10-11 | 2015-07-15 | 王纯治 | Traditional Chinese medicine mixture for treating varicocele |
| CN105796789A (en) * | 2014-12-14 | 2016-07-27 | 张雪松 | Traditional Chinese medicine preparation for treating coronary heart disease |
| CN104606287A (en) * | 2015-02-15 | 2015-05-13 | 天津市宝坻区人民医院 | Traditional Chinese medicine preparation for raising amniotic fluid during gestation period |
| CN105582280A (en) * | 2016-01-21 | 2016-05-18 | 李宪秋 | Traditional Chinese medicine preparation for treating angina pectoris of coronary heart disease |
| CN108096433A (en) * | 2017-12-31 | 2018-06-01 | 何江 | Treat Chinese medicinal capsule of Senile Coronary Heart Disease syndrome of blood stasis due to qi deficiency and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1679843A (en) * | 2005-01-27 | 2005-10-12 | 朱腾月 | Oral medicine for treating thromboangitis obliterans |
-
2012
- 2012-12-21 CN CN201210561123.3A patent/CN103041336B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1679843A (en) * | 2005-01-27 | 2005-10-12 | 朱腾月 | Oral medicine for treating thromboangitis obliterans |
Non-Patent Citations (4)
| Title |
|---|
| 时亮等.通络药物在慢性心力衰竭中的应用.《北京中医药》.2011,第30卷(第06期), |
| 李映霞等.活血化瘀法治疗慢性肺源性心脏病研究概况.《江西中医药》.2000,第31卷(第01期), |
| 活血化瘀法治疗慢性肺源性心脏病研究概况;李映霞等;《江西中医药》;20000229;第31卷(第01期);54-56 * |
| 通络药物在慢性心力衰竭中的应用;时亮等;《北京中医药》;20110630;第30卷(第06期);409-411 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103041336A (en) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007191A (en) | Chinese medicinal composition for treating jaundice | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN105561214A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103463561A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae | |
| CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
| CN103316204B (en) | One treats hypertensive Chinese medicine composition | |
| CN103191383A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
| CN103272143A (en) | Traditional Chinese medicine composition for treating acne | |
| CN104173565A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN103007077A (en) | Chinese medicinal composition for treating climacteric syndrome | |
| CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN102512645B (en) | Traditional Chinese medicine composition for treating lumbago due to cold dampness | |
| CN103041271B (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN102784212B (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
| CN103830682A (en) | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes | |
| CN103316226B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103330814A (en) | Traditional Chinese medicine composition for treating deficiency of kidney yang | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140625 Termination date: 20141221 |
|
| EXPY | Termination of patent right or utility model |